8-KThe WireRoutine
Bylaw Amendment · Reg FD Disclosure
Filed Mar 10, 2026 · 3mo ago · Accession 0001437749-26-007422
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- FILANA THERAPEUTICS, INC.
- Ticker
- FLNA
- CIK
- 1069530
- Form type
- 8-K
- Filing date
- Mar 10, 2026
- Report date
- Mar 10, 2026
- Document
- sava20260307_8k.htm
- Size
- 365 KB